{"database": "lobbying", "table": "lobbying_activities", "rows": [[1593548, "542498f4-cbfc-4b47-81cd-9e1fa1f30bb0", "Q3", "GSK (FKA GLAXOSMITHKLINE INC.)", 16293, "GSK (FKA GLAXOSMITHKLINE INC.)", 2014, "third_quarter", "TAR", "H.R. 6726 - U.S. Job Creation and Manufacturing Competitiveness Act of 2013 - provisions related to the emporary duty suspension for preparations, such as tablets or chewing gum, intended to assist smokers to stop smoking (provided for in subheading\n2106.90.99)", "HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)", null, 1140000, 0, 0, "2014-10-17T14:30:30.990000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1593548"], "units": {}, "query_ms": 65.82616199739277, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}